Adhesion and migration of
tumor cells on and through the vascular endothelium are critical steps of the metastatic invasion. We investigated the roles of
E-selectin and of stress-activated
protein kinase-2 (
SAPK2/p38) in modulating endothelial adhesion and transendothelial migration of HT-29 colon
carcinoma cells.
Tumor necrosis factor alpha (
TNF alpha) strongly increased the expression of
E-selectin in human umbilical vein endothelial cells (HUVEC). This effect was independent of the activation of
SAPK2/p38 induced by
TNF alpha. Adhesion of HT-29 cells on a monolayer of HUVEC pretreated with
TNF alpha was dependent on
E-selectin expression but was independent of
SAPK2/p38 activity of both HUVEC and
tumor cells. The adhesion of HT-29 cells to
E-selectin-expressing HUVEC led to the activation of
SAPK2/p38 in the
tumor cells as reflected by the increased phosphorylation of the actin-polymerizing factor HSP27 by
mitogen-activated protein kinase 2/3, a direct target of
SAPK2/p38. Moreover, a recombinant
E-selectin/Fc chimera quickly increased the activation of
SAPK2/p38 in HT-29 cells. Blocking the increased activity of
SAPK2/p38 of HT-29 cells by
SB203580 or by expressing a dominant negative form of
SAPK2/p38 inhibited their transendothelial migration. Similarly, HeLa cells stably expressing a
kinase-inactive mutant of
SAPK2/p38 showed a decreased capacity to cross a layer of HUVEC. Overall, our results suggest that the regulation of transendothelial migration of
tumor cells involves two essential steps as follows: adhesion to the endothelium through adhesion molecules, such as
E-selectin, and increased motogenic potential through adhesion-mediated activation of the
SAPK2/p38 pathway.